Serum CC-10 in Inflammatory Lung Diseases

Publisher： Karger

E-ISSN： 1423-0356|71|5|505-510

ISSN： 0025-7931

Source： Respiration, Vol.71, Iss.5, 2004-10, pp. : 505-510

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In vitro pharmacoregulation of CC chemokine ligand 5 and its receptor CCR5 in diffuse lung diseases

By Sekerova Veronika   Subrtova Daniela   Mrazek Frantisek   Gibejova Agata   Kolek Vitezslav   M. du Bois Roland   Petrek Martin  

Mediators of Inflammation, Vol. 12, Iss. 4, 2003-08 ,pp. : 215-220

Informa Healthcare

Access to resources Recommend Favorite

Elevated miR‐122 serum levels are an independent marker of liver injury in inflammatory diseases

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 4, 2015-04 ,pp. : 1172-1184

John Wiley & Sons Inc

Access to resources Recommend Favorite

Serum inflammatory factors and circulating immunosuppressive cells are predictive markers for efficacy of radiofrequency ablation in non‐small‐cell lung cancer

By  

CLINICAL & EXPERIMENTAL IMMUNOLOGY, Vol. 180, Iss. 3, 2015-06 ,pp. : 467-474

John Wiley & Sons Inc

Access to resources Recommend Favorite

Osteoporosis in inflammatory joint diseases

By Roux C.  

Osteoporosis International, Vol. 22, Iss. 2, 2011-02 ,pp. : 421-433

Springer Publishing Company

Access to resources Recommend Favorite

Apoptosis in Inflammatory Diseases

By  

International Archives of Allergy and Immunology, Vol. 118, Iss. 2-4, 1999-04 ,pp. : 261-262

Karger

Access to resources Recommend Favorite